Newsroom

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today provided a corporate update following the filing of its 10-K on Friday, March 27, 2026, which reported financial results for the fourth quarter and year ended December 31, 2025. CEO Commentary: “The year 2025 was a year of important scientific progress for En...

WASHINGTON--(BUSINESS WIRE)--The latest GAO report confirms what CCAGW has long warned: Since CMMI was established in Obamacare in 2010, it has squandered the taxpayer’s money....

WASHINGTON--(BUSINESS WIRE)--The Foundation for the Development of Western Syria (the “Foundation”) expresses its strongest condemnation of a series of extremist attacks and coordinated movements witnessed across several Syrian provinces. These developments represent a dangerous escalation that threatens Syria’s social fabric and specifically targets the country’s indigenous Christian community. I. Attack on the City of Al-Suqaylabiyah According to field sources, a coordinated attack was carrie...

PONTIAC, Mich.--(BUSINESS WIRE)--UWMC today issued the following statement regarding its proposal to acquire TWO. “The actions by TWO’s management and board do not reflect the best interests of their shareholders. The same team that had to settle a $375 million lawsuit this past summer is at it again. TWO’s decision appears to be driven more by ego, than by sound judgment. The deal for us was a strategy to acquire their servicing book, not their operations, as ultimately there are no operationa...

IRVINE, California--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" o l'"Azienda"), un'organizzazione di servizi di gestione che opera in un ampio ventaglio di attività di franchising in diversi campi medici, ha annunciato oggi i propri risultati finanziari per il quarto trimestre dell'esercizio fiscale 2025 (i tre mesi conclusisi il 31 dicembre 2025) e per l'intero esercizio fiscale 2025 (i dodici mesi conclusisi il 31 dicembre 2025). Punti salienti del qu...

IRVINE, California--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) («SBC Medical» o la «Empresa»), una organización de servicios de gestión que opera una amplia cartera de franquicias en diversos campos médicos, ha anunciado hoy sus resultados financieros correspondientes al cuarto trimestre del ejercicio fiscal 2025 (tres meses concluidos el 31 de diciembre de 2025) y al ejercicio fiscal completo 2025 (doce meses finalizados el 31 de diciembre de 2025). Aspectos destaca...

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” of het “Bedrijf”), een Management Services Organization die actief is in een grote verscheidenheid aan franchiseactiviteiten in diverse medische domeinen, maakte vandaag haar financiële resultaten bekend voor het vierde kwartaal van boekjaar 2025 (drie maanden die op 31 december 2025 afliepen) en voor het volledige boekjaar 2025 (twaalf maanden die op 31 december 2025 afliepen). Belangrijkste p...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Axway, ein Unternehmen der 74Software-Gruppe (Euronext: 74SW) und weltweit führender Anbieter im Bereich des föderierten API-Managements und der Unternehmensintegration, wurde im IDC MarketScape: Worldwide API Management 2026 Vendor Assessment als Leader ausgezeichnet.1 Axway Amplify verbindet, koordiniert und automatisiert die Datenintegration auf sichere Weise. Unternehmen aus den Bereichen Finanzdienstleistungen, Fertigung, Gesundheitswesen und anderen Bra...

TORONTO--(BUSINESS WIRE)--Magellan Aerospace Corporation (“Magellan” or the “Corporation”) released its financial results for the fourth quarter of 2025. All amounts are expressed in Canadian dollars unless otherwise indicated. The results are summarized as follows:     Three month period ended December 31 Twelve month period ended December 31 Expressed in thousands of Canadian dollars, except per share amounts 2025 2024 Change 2025 2024 Change Revenues   278,325 240,704 15.6% 1,044,682 942,368...

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission. The Company’s revenues for 2025 increased 15.8%. The Company’s revenues were approximately $38.3 million in 2025 as compared to approximat...